Corporate Culture Has No Place in Academia
By Olof Hallonsten,
Nature News
| 10. 03. 2016
The eyes of the world are on the Karolinska Institute in Stockholm this week for the announcement of the Nobel prize in medicine, but an ugly medical scandal lurks in the background. The case of Paolo Macchiarini involved the deaths of multiple patients and several instances of research fraud, and has exposed the misdeeds of a single professor. But it also demonstrates the risks of academic capitalism: a global trend that turns universities into businesses. In this respect, the story has wider lessons for us all.
As academic capitalism spreads, universities abandon traditional meritocratic and collegial governance to hunt money, prestige and a stronger brand. Here in Sweden, this shift has been especially profound: since the 1980s, the university system has been deregulated, and its core principles gradually replaced by management practices from the corporate world. Government research policy over the past decade has further pushed universities to centralize their strategic management and increase their international visibility. Major strategic funding programmes included one to recruit international star scientists.
An investigation into the Macchiarini scandal, led by a former president of...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...